Boston Historical Income Statement

BSX Stock

USD 90.66 0.09 0.1%

Historical analysis of Boston Scientific income statement accounts such as Interest Expense of 193.9 M, Selling General Administrative of 5.2 B or Total Revenue of 15 B can show how well Boston Scientific Corp performed in making a profits. Evaluating Boston Scientific income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Boston Scientific's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Boston Scientific Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Boston Scientific Corp is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Boston Income Statement Analysis

Boston Scientific Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Boston Scientific shareholders. The income statement also shows Boston investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Boston Scientific Income Statement Chart

At this time, Boston Scientific's Income Before Tax is fairly stable compared to the past year. Net Income is likely to rise to about 1.7 B in 2024, whereas Interest Expense is likely to drop slightly above 193.9 M in 2024.

Depreciation And Amortization Total Revenue Gross Profit Other Operating Expenses Ebit

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Total Revenue

Total revenue comprises all receipts Boston Scientific Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Boston Scientific Corp minus its cost of goods sold. It is profit before Boston Scientific operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Boston Scientific Corp. It is also known as Boston Scientific overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Boston Scientific's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

	2021	2022	2023	2024 (projected)
Gross Profit	8.1B	8.7B	9.9B	10.4B
Total Revenue	11.9B	12.7B	14.2B	15.0B

Gross Profit Total Revenue

Boston Scientific income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.47	0.91	0.91	0.89	0.93	0.61	0.58	0.82	0.93	0.92	0.5	0.21	0.29	0.2	0.74	-0.56	0.33	-0.26	0.29	0.36	-0.08	-0.51	0.48	0.87
Interest Expense	0.47		0.59	0.56	0.54	0.57	0.2	0.26	0.37	0.59	0.56	0.06	-0.1	0.31	-0.43	0.79	0.2	0.44	-0.02	-0.1	-0.37	0.19	-0.77	0.09	0.49
Selling General Administrative	0.91	0.59		1.0	0.99	1.0	0.59	0.77	0.92	0.98	0.99	0.51	0.17	0.43	-0.01	0.87	-0.54	0.5	-0.23	0.02	0.16	-0.3	-0.47	0.44	0.78
Total Revenue	0.91	0.56	1.0		1.0	1.0	0.59	0.81	0.95	0.99	0.99	0.52	0.15	0.42	0.01	0.85	-0.58	0.49	-0.22	0.0	0.18	-0.32	-0.45	0.45	0.78
Gross Profit	0.89	0.54	0.99	1.0		0.99	0.61	0.83	0.95	0.97	0.99	0.54	0.18	0.45	-0.01	0.84	-0.59	0.51	-0.25	-0.04	0.17	-0.36	-0.44	0.44	0.77
Other Operating Expenses	0.93	0.57	1.0	1.0	0.99		0.56	0.76	0.92	0.99	1.0	0.48	0.13	0.39	0.01	0.85	-0.57	0.46	-0.2	0.05	0.19	-0.28	-0.46	0.48	0.8
Operating Income	0.61	0.2	0.59	0.59	0.61	0.56		0.55	0.64	0.54	0.57	0.98	0.87	0.81	-0.01	0.41	-0.41	0.79	-0.89	-0.01	0.12	-0.34	-0.37	0.34	0.63
Ebit	0.58	0.26	0.77	0.81	0.83	0.76	0.55		0.94	0.75	0.74	0.59	0.23	0.46	0.04	0.61	-0.62	0.5	-0.26	-0.27	0.15	-0.55	-0.11	0.28	0.46
Ebitda	0.82	0.37	0.92	0.95	0.95	0.92	0.64	0.94		0.92	0.9	0.62	0.25	0.44	0.11	0.74	-0.67	0.49	-0.29	-0.07	0.26	-0.42	-0.29	0.4	0.69
Cost Of Revenue	0.93	0.59	0.98	0.99	0.97	0.99	0.54	0.75	0.92		0.97	0.45	0.09	0.34	0.05	0.86	-0.55	0.41	-0.15	0.1	0.2	-0.21	-0.47	0.46	0.8
Total Operating Expenses	0.92	0.56	0.99	0.99	0.99	1.0	0.57	0.74	0.9	0.97		0.49	0.15	0.41	-0.01	0.85	-0.57	0.48	-0.22	0.02	0.17	-0.32	-0.46	0.48	0.79
Income Before Tax	0.5	0.06	0.51	0.52	0.54	0.48	0.98	0.59	0.62	0.45	0.49		0.91	0.79	0.06	0.31	-0.44	0.75	-0.91	-0.08	0.18	-0.4	-0.23	0.29	0.51
Total Other Income Expense Net	0.21	-0.1	0.17	0.15	0.18	0.13	0.87	0.23	0.25	0.09	0.15	0.91		0.71	0.06	0.02	-0.16	0.66	-0.95	0.0	0.12	-0.23	-0.13	0.07	0.25
Net Income	0.29	0.31	0.43	0.42	0.45	0.39	0.81	0.46	0.44	0.34	0.41	0.79	0.71		-0.57	0.31	-0.24	0.99	-0.79	-0.39	-0.46	-0.46	-0.47	0.35	0.53
Income Tax Expense	0.2	-0.43	-0.01	0.01	-0.01	0.01	-0.01	0.04	0.11	0.05	-0.01	0.06	0.06	-0.57		-0.1	-0.21	-0.59	0.06	0.52	0.98	0.21	0.45	-0.17	-0.18
Research Development	0.74	0.79	0.87	0.85	0.84	0.85	0.41	0.61	0.74	0.86	0.85	0.31	0.02	0.31	-0.1		-0.11	0.43	-0.09	0.07	0.03	-0.17	-0.51	0.33	0.6
Selling And Marketing Expenses	-0.56	0.2	-0.54	-0.58	-0.59	-0.57	-0.41	-0.62	-0.67	-0.55	-0.57	-0.44	-0.16	-0.24	-0.21	-0.11		-0.19	0.21	0.11	-0.32	0.42	-0.08	-0.55	-0.53
Net Income From Continuing Ops	0.33	0.44	0.5	0.49	0.51	0.46	0.79	0.5	0.49	0.41	0.48	0.75	0.66	0.99	-0.59	0.43	-0.19		-0.74	-0.37	-0.47	-0.46	-0.51	0.33	0.53
Non Recurring	-0.26	-0.02	-0.23	-0.22	-0.25	-0.2	-0.89	-0.26	-0.29	-0.15	-0.22	-0.91	-0.95	-0.79	0.06	-0.09	0.21	-0.74		0.13	-0.02	0.31	0.25	-0.22	-0.34
Non Operating Income Net Other	0.29	-0.1	0.02	0.0	-0.04	0.05	-0.01	-0.27	-0.07	0.1	0.02	-0.08	0.0	-0.39	0.52	0.07	0.11	-0.37	0.13		0.5	0.41	0.1	0.01	0.07
Tax Provision	0.36	-0.37	0.16	0.18	0.17	0.19	0.12	0.15	0.26	0.2	0.17	0.18	0.12	-0.46	0.98	0.03	-0.32	-0.47	-0.02	0.5		0.1	0.38	-0.06	-0.03
Interest Income	-0.08	0.19	-0.3	-0.32	-0.36	-0.28	-0.34	-0.55	-0.42	-0.21	-0.32	-0.4	-0.23	-0.46	0.21	-0.17	0.42	-0.46	0.31	0.41	0.1		-0.24	-0.41	-0.08
Net Interest Income	-0.51	-0.77	-0.47	-0.45	-0.44	-0.46	-0.37	-0.11	-0.29	-0.47	-0.46	-0.23	-0.13	-0.47	0.45	-0.51	-0.08	-0.51	0.25	0.1	0.38	-0.24		-0.16	-0.72
Reconciled Depreciation	0.48	0.09	0.44	0.45	0.44	0.48	0.34	0.28	0.4	0.46	0.48	0.29	0.07	0.35	-0.17	0.33	-0.55	0.33	-0.22	0.01	-0.06	-0.41	-0.16		0.58
Extraordinary Items	0.87	0.49	0.78	0.78	0.77	0.8	0.63	0.46	0.69	0.8	0.79	0.51	0.25	0.53	-0.18	0.6	-0.53	0.53	-0.34	0.07	-0.03	-0.08	-0.72	0.58

Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	564M	1.1B	1.1B	1.1B	1.2B	1.3B
Interest Expense	473M	361M	341M	470M	265M	193.9M
Selling General Administrative	3.9B	3.8B	4.4B	4.5B	5.0B	5.2B
Total Revenue	10.7B	9.9B	11.9B	12.7B	14.2B	15.0B
Gross Profit	7.6B	6.4B	8.1B	8.7B	9.9B	10.4B
Other Operating Expenses	9.0B	9.2B	10.1B	10.6B	12.0B	12.6B
Operating Income	1.5B	1.0B	2.0B	1.6B	2.3B	2.5B
Ebit	1.5B	389M	1.4B	1.6B	2.3B	2.4B
Ebitda	2.1B	1.5B	2.5B	2.7B	3.5B	3.6B
Cost Of Revenue	3.2B	3.5B	3.8B	4.0B	4.3B	4.6B
Total Operating Expenses	5.8B	5.7B	6.3B	6.6B	7.6B	7.9B
Income Before Tax	687M	(138M)	1.1B	1.1B	2.0B	2.1B
Total Other Income Expense Net	(831M)	(1.1B)	(123M)	(508M)	(358M)	(375.9M)
Net Income	4.7B	(140M)	1.0B	698M	1.6B	1.7B
Income Tax Expense	(4.0B)	2M	36M	443M	393M	412.7M
Research Development	1.2B	1.1B	1.2B	1.3B	1.4B	884.9M
Net Income Applicable To Common Shares	4.7B	(115M)	986M	642M	738.3M	775.2M
Net Income From Continuing Ops	4.7B	(81M)	1.0B	698M	1.2B	1.3B
Non Recurring	323M	908M	889M	376M	338.4M	321.5M
Non Operating Income Net Other	(358M)	362M	218M	(38M)	(43.7M)	(41.5M)
Tax Provision	(4.0B)	2M	36M	443M	647M	679.4M
Interest Income	30M	361M	341M	470M	22M	20.9M
Net Interest Income	(443M)	(361M)	(341M)	(470M)	(254M)	(266.7M)
Reconciled Depreciation	1.0B	1.1B	741M	803M	1.2B	1.0B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boston Historical Income Statement

About Boston Income Statement Analysis

Boston Scientific Income Statement Chart

Depreciation And Amortization

Total Revenue

Gross Profit

Other Operating Expenses

Boston Scientific income statement Correlations

Boston Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Boston Scientific income statement Accounts

Also Currently Popular

Additional Tools for Boston Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Revenue	+ 1.0	Selling General Administrative
Other Operating Expenses	+ 1.0	Selling General Administrative
Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Gross Profit	+ 0.99	Selling General Administrative

Non Recurring	- 0.95	Total Other Income Expense Net
Non Recurring	- 0.91	Income Before Tax
Non Recurring	- 0.89	Operating Income
Non Recurring	- 0.79	Net Income
Net Interest Income	- 0.77	Interest Expense
Non Recurring	- 0.74	Net Income From Continuing Ops